Connect with us
Information

Australia
North America
World

Investing News Network Your trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

pharmala biotech holdings inc.

POPULAR ARTICLES

PharmAla Completes GMP Manufacturing of Drug Substance components for ALA-002 Provides Corporate Update Regarding ALA-002 Asset

PharmAla Completes GMP Manufacturing of Drug Substance components for ALA-002 Provides Corporate Update Regarding ALA-002 Asset

PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. in a Transaction Valued at Over $100 Million

PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. in a Transaction Valued at Over $100 Million

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

LATEST ARTICLES

PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01

PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01

PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01

PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01

PharmAla Issues Q2 Financial Statements and Grants Options

PharmAla Issues Q2 Financial Statements and Grants Options

PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order

PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order

PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders

PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders

PharmAla To Supply Amsterdam UMC with LaNeo MDMA, Including Development of New Single-Capsule Stability Data

PharmAla To Supply Amsterdam UMC with LaNeo MDMA, Including Development of New Single-Capsule Stability Data

PharmAla Announces Changes to Board of Directors

PharmAla Announces Changes to Board of Directors

PharmAla To Supply Østfold Hospital Trust with LaNeo MDMA for Clinical Research

PharmAla To Supply Østfold Hospital Trust with LaNeo MDMA for Clinical Research

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance

PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance

PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules

PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules

PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital

PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital

Latest News

Drilling Identifies Extensive Copper Mineralisation within Nifty Waste Dump

Armidale Antimony Target Expanded Ahead of July Drilling

Homerun Resources Inc. Announces up to $15 Million Convertible Security Financing with Lind Partners Under Engagements with Benchmark/Stonex

EnerCom Announces Liberty Energy as a Keynote Speaker at the 31st Annual EnerCom Denver- The Energy Investment Conference, August 17-19, 2026, in Denver, Colorado

Goldgroup Announces Effective Date of Share Consolidation

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
- Lithium
- Cobalt
- Graphite
Energy
- Uranium
- Oil and Gas

Base Metals
- Copper
- Nickel
- Zinc
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Westport

Westport (WPRT)

WPRT

Star Copper

Star Copper (STCU:CC)

STCU:CC

Syntholene Energy

Syntholene Energy (ESAF:CC)

ESAF:CC

Gemdale Gold

Gemdale Gold (GEMG:CC)

GEMG:CC

Premier American Uranium

Premier American Uranium (PUR:CC)

PUR:CC

VanadiumCorp Resource

VanadiumCorp Resource (VRB:CC)

VRB:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES